Centocor

Company snapshot

Subsidiary of Johnson & Johnson, Centocor is a biotechnology company that was founded in Philadelphia in 1979 with an initial goal of developing new diagnostic assays using monoclonal antibody technology. In 1982 Centocor developed their first product approved by the U.S. Food and Drug Administration (FDA) — a diagnostic test used to detect the rabies virus, and in that same year transitioned into

• 2 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 US patent(s) indexed to this assignee profile.
• 2 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Centocor. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Centocor.

1. Jun 8, 2026 Clinical update

   Placebo, Velcade and dexamethasone — Phase 3

2. Jun 8, 2026 Clinical update

   Placebo injections — Phase 3

3. Nov 13, 2008 Patent grant

   MODÈLE DE MARQUEUR DE MATRICE ET PROCÉDÉS POUR ÉVALUER ET TRAITER L'ARTHRITE ET DES TROUBLES ASSOCIÉS

View all clinical trial activity →

• What is Centocor?

  Centocor is a pharma organization headquartered in EU. Primary therapeutic focus areas include Rheumatoid Arthritis, Multiple Myeloma. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, an

• Is Centocor publicly traded?

  Centocor appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Centocor develop or market?

  We link 4 drug profile(s) where Centocor is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/centocor-b-v#company-drugs.

• What are the latest developments for Centocor?

  In the last 12 months our linked public records show 2 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Centocor focus on?

  Centocor focuses on Rheumatoid Arthritis, Multiple Myeloma based on our analysis of their pipeline programs and drug development activities.